辅助治疗预防和治疗宫腔粘连的效果:随机对照试验的网络Meta分析
该网络Meta分析纳入20篇随机对照试验共1891例患者,评估辅助治疗预防和治疗宫腔粘连的效果。预防方面,透明质酸钠-羧甲基纤维素膜(ACH)降低宫腔粘连发生率最有效(SUCRA评分93.3%);治疗方面,自交联透明质酸(ACP)联合球囊降低复发最有效(SUCRA评分96.3%)。
要点
- 预防宫腔粘连:ACH的SUCRA评分93.3%,intercoat为74.7%,米索前列醇为68.6%。
- 预防严重宫腔粘连:ACP的SUCRA评分83.2%,intercoat为66.4%。
- 治疗宫腔粘连:ACP联合球囊的SUCRA评分96.3%,冻干羊膜联合球囊为62.7%。
核心结论
- 根据预防分析,ACH和intercoat最可能预防宫腔粘连发生。
- 在预防严重宫腔粘连的分析中,ACP和intercoat具有显著优势且可靠性高。
- 在治疗分析中,ACP联合球囊和冻干羊膜制剂联合球囊最可能降低粘连松解术后的宫腔粘连复发和宫腔粘连评分。
研究设计与样本
- 网络Meta分析,检索PubMed、Embase和Cochrane Library截至2017年5月5日,无语言限制。
- 纳入20篇随机对照试验,共1891例患者。
- 主要结局为预防研究的宫腔粘连发生率和治疗研究的宫腔粘连复发率。
- 次要结局包括宫腔粘连评分和宫腔粘连严重程度率。
- 采用累积排序曲线下面积(SUCRA)对治疗进行排序。
主要发现
- 预防相关研究中,ACH(n=10,SUCRA评分93.3%)降低宫腔粘连发生率最有效,其次为intercoat(n=10,SUCRA评分74.7%)和米索前列醇(n=10,SUCRA评分68.6%)。
- 预防严重宫腔粘连方面,ACP(n=3,SUCRA评分83.2%)和intercoat(n=3,SUCRA评分66.4%)各自对应较高的预防效果。
- 治疗相关研究中,ACP联合球囊(n=4,SUCRA评分96.3%)和冻干羊膜移植联合球囊(n=4,SUCRA评分62.7%)最有效降低宫腔粘连复发,且具有高效降低宫腔粘连评分的概率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Intrauterine adhesions (IUAs) can lead to partial or complete closure of the uterine cavity, which may result in symptoms including abnormal menstruation, infertility, and pelvic pain. A network meta-analysis was performed to assess the effect of adjuvant therapy on the prevention and treatment of IUAs. We searched electronic databases, including PubMed, Embase, and the Cochrane Library, up to May 5, 2017, without language restrictions. The primary outcomes in the present analysis were the rate of IUAs for prevention and the rate of IUA recurrence for treatment. The secondary outcomes included the IUA score and the rate of severity of IUAs. The treatments were then ranked by the surface under the cumulative ranking curve (SUCRA). We included 20 articles that involved a total of 1891 patients in our analysis. In the outcomes of prevention-related studies, an alginate hyaluronate-carboxymethylcellulose membrane (ACH) (n = 10, SUCRA score = 93.3%) was the adjuvant treatment that most effectively reduced IUA incidence. It was followed by intercoat (n = 10, SUCRA score = 74.7%) and misoprostol (n = 10, SUCRA score = 68.6%). In addition, auto-cross-linked hyaluronic acid (ACP) (n = 3, SUCRA score = 83.2%) and intercoat (n = 3, SUCRA score = 66.4%) each corresponded to a relatively high preventive effect against severe IUAs. In the treatment-related studies, ACP plus a balloon (n = 4, SUCRA score = 96.3%) and a freeze-dried amnion graft plus a balloon (n = 4, SUCRA score = 62.7%) most effectively reduced IUA recurrence and had a high probability of most effectively reducing IUA scores. Therefore, according to the prophylactic analysis, ACH and intercoat were most likely to prevent IUA development. In our analysis of agents used to prevent severe IUAs, we found that ACP and intercoat provided significant advantages and had high reliability. In our analysis of treatments, ACP plus a balloon and freeze-dried amniotic agents plus a balloon were most likely to reduce IUA recurrence and IUA scores after adhesiolysis.
引用
- Yan Y, Xu D. The Effect of Adjuvant Treatment to Prevent and Treat Intrauterine Adhesions: A Network Meta-Analysis of Randomized Controlled Trials. J Minim Invasive Gynecol. 2017. PMID: 28893657. doi:10.1016/j.jmig.2017.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。